Evidence map›Paper›PMID 29018410›Full record

ReviewFrontiers in microbiology2017

Next-Generation Beneficial Microbes: The Case of

Patrice D Cani, Willem M de Vos

Abstract readReview
In one paragraph

Review in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 544 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
544citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

544 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Probiotic Supplementation and its Potential Benefits in Type 2 Diabetes: A Meta-analysis.Endocrine, metabolic & immune disorders drug targets · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Journal of microbiology and biotechnology · 2026
    Article
  17. Review
  18. Review
  19. Article
  20. Article

484 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Patrice D CaniWalloon Excellence in Life Sciences and Biotechnology (WELBIO), Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université catholique de LouvainBrussels, Belgium.
Willem M de VosLaboratory of Microbiology, Wageningen UniversityWageningen, Netherlands.

Funding

European Research Council 250172European Research Council 336452
6 · The paper itself

Abstract

Metabolic disorders associated with obesity and cardiometabolic disorders are worldwide epidemic. Among the different environmental factors, the gut microbiota is now considered as a key player interfering with energy metabolism and host susceptibility to several non-communicable diseases. Among the next-generation beneficial microbes that have been identified,

Indexed as

Akkermansia muciniphiladiabetes mellitusgut barrier functionobesityprobiotics and prebioticstype 2

Identifiers

PMID29018410
PMCPMC5614963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.